| Product NDC: | 0904-6041 |
| Proprietary Name: | sodium polystyrene sulfonate |
| Non Proprietary Name: | sodium polystyrene sulfonate |
| Active Ingredient(s): | 1 g/g & nbsp; sodium polystyrene sulfonate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0904-6041 |
| Labeler Name: | Major Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040905 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20091118 |
| Package NDC: | 0904-6041-27 |
| Package Description: | 454 g in 1 BOTTLE (0904-6041-27) |
| NDC Code | 0904-6041-27 |
| Proprietary Name | sodium polystyrene sulfonate |
| Package Description | 454 g in 1 BOTTLE (0904-6041-27) |
| Product NDC | 0904-6041 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sodium polystyrene sulfonate |
| Dosage Form Name | POWDER |
| Route Name | ORAL |
| Start Marketing Date | 20091118 |
| Marketing Category Name | ANDA |
| Labeler Name | Major Pharmaceuticals |
| Substance Name | SODIUM POLYSTYRENE SULFONATE |
| Strength Number | 1 |
| Strength Unit | g/g |
| Pharmaceutical Classes |